Similares a What the Phase 3 AD109 Data Mean for Sleep Apnea, With Patrick John Strollo, MD

20 vecinos (text_768) · 142 views · HCPLive · Estados Unidos


★	What the Phase 3 AD109 Data Mean for Sleep Apnea, With Patrick John Strollo, MD	HCPLive @hcplivenews	142	Estados Unidos
11	OSA (Obstructive Sleep Apnea) Comparison of Treatments	MedCram - Medical Lectures Explained CLEARLY @medcram	31.6K	Estados Unidos	83
18	Your Brain Ages FAST At Night	Dr Brad Stanfield @drbradstanfield	5.6K	Nueva Zelanda	83
10	Inspire Implant for Sleep Apnea: What Your Actual Chance of Success Looks Like	CPAP Reviews @cpapreviews	2.5K	Australia	83
17	Patient Perspectives on a Potential New Dermatomyositis Therapy: Insights from Phase 3 VALOR Trial	The Myositis Association (TMA) @myositisassociation	371	Estados Unidos	83
7	Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD \| ATS 2026	HCPLive @hcplivenews	301	Estados Unidos	84
4	Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD	HCPLive @hcplivenews	198	Estados Unidos	85
12	Healthy Smiles, Airways, & Sleep: Orthodontic & Pulmonary Considerations	The Marfan Foundation @themarfanfoundation	178	Estados Unidos	83
6	Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results	HCPLive @hcplivenews	156	Estados Unidos	84
1	AD109 Shows Promise as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD	HCPLive @hcplivenews	129	Estados Unidos	92
15	Tezepelumab Reduced Severe Asthma Exacerbations Across Phenotypes \| ATS 2026	HCPLive @hcplivenews	122	Estados Unidos	83
9	Sotatercept May Improve RV Function in Group 3 3 Pulmonary Hypertension	HCPLive @hcplivenews	112	Estados Unidos	84
3	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	86
19	Respiratory desease caused by Aerotoxic Syndrome.	Dr. Jordi Roig Cutillas @dr.jordiroigcutillas	97	Andorra	83
5	Efdoralprin Alfa vs Standard of Care in AATD: Phase 2 ElevAATe Results	HCPLive @hcplivenews	82	Estados Unidos	84
8	SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma	HCPLive @hcplivenews	78	Estados Unidos	84
2	ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	55	Estados Unidos	87
16	Entrevista al Dr. Juan Silva del Centro de Investig. en Fisiolog. y Med. de altura U. de Antofagasta	Antofagasta TV @antofagastatv30	44	Chile	83
13	Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients \| ATS 2026 \| Gerald Criner, MD	HCPLive @hcplivenews	29	Estados Unidos	83
20	Navigating a New Era of PH Management as an APP, With Susanne McDevitt, DNP	HCPLive @hcplivenews	15	Estados Unidos	83
14	Why 68% of Americans Have Sleep Apnea and Don't Know It	HealthandWellnessPlus @healthandwellnessplus	11	Estados Unidos	83